Homepage - Ophthalmology Advisor
Psychiatry Advisor spoke with Michelle Lewis to discuss how color psychology can play an important role in the design of health care spaces and physician branding. Factors preventing more widespread use of biosimilars in oncology include the cost and complexity of biosimilar development, oncologists’ lack of knowledge about biosimilars, and ...
Dexamethasone Implants Improve DME+HRID Outcomes vs …
15 hours ago — Intravitreal dexamethasone implants (DEX) better improve visual and anatomical outcomes for diabetic macular edema (DME) with hyperreflective intraretinal dots (HRID) compared with brolucizumab injection. These results of a retrospective, single-center study from India were published in Clinical Ophthalmology.. The burden of DME is expected to increase with the global rise of diabetes.
Intraoperative Aberrometry Offers Superior IOL Power Accuracy ...
15 hours ago — The assessment of intraoperative aberrometry (IA) vs preoperative biometry for intraocular lens (IOL) power calculation in cataract surgery indicates that intraoperative aberrometry may offer superior accuracy in specific scenarios, according to study results published in Ophthalmology. Researchers performed a comprehensive literature review ...
Low Dose Pilocarpine Drop Shows Strong Efficacy
1 day ago — CSF-1, a low-dose, preservative-free, pilocarpine ophthalmic solution, consistently reduces pupil size and improves visual outcomes for patients with presbyopia, according to the results of the phase 3, NEAR-1 study (Near Eye-vision Acuity Restoration; ClinicalTrials.gov identifier: NCT04599933) and NEAR-2 (ClinicalTrials.gov identifier ...
Vorolanib Insert Shows Early Visual, Structural Improvements ...
1 day ago — Each patient in the trial was randomly assigned to receive either a 1.3 mg or 2.7 mg dose of vorolanib via the insert, or aflibercept injections. The company reports that the trial shows a BCVA improvement of +8.9 letters from baseline for patients who received the 2.7 mg dose of vorolanib, which they compared with the aflibercept (+3.2 letters).
Hyperbaric Oxygen Therapy Improves Vision After CRAO
2 days ago — Early hyperbaric oxygen therapy (HBOT) for central retinal artery occlusion (CRAO) is associated with improved visual outcomes, according to the results of a retrospective cohort study published in American Journal of Ophthalmology.. CRAO generally causes severe acute vision loss but consensus guidelines for management are lacking. HBOT is thought to increase oxygen in the tissues and preserve ...
Polygenic Risk Score Predicts Risk for POAG - Ophthalmology …
2 days ago — A polygenic risk score (PRS) threshold can identify individuals at high and low risk for developing primary open-angle glaucoma (POAG), according to research published in JAMA Ophthalmology. Researchers conducted a post hoc analysis of the Ocular Hypertension Treatment Study (OHTS) (ClinicalTrials.gov Identifier: NCT00000125), a multicenter ...
High-Dose Aflibercept Improves Vision in DME For All Subgroups ...
Oct 22, 2024 — High-dose aflibercept (8mg) for diabetic macular edema (DME) produces meaningful improvements in best-correct visual acuity (BCVA) across demographic subgroups such as sex, age, race, ethnicity, BCVA, and central retinal thickness, according to a subgroup analysis of the phase 2/3 PHOTON study (ClinicalTrials.gov Identifier: NCT04429503) presented at the American Academy of Ophthalmology 2024 ...
Intraocular Lens Choice Dependent on Lifestyle, Expectations ...
October 4, 2024. Cataract surgeons are responsible for advising patients on a decision that will have lifelong implications. Identifying the intraocular lens (IOL) choice most suited for a particular patient’s lifestyle should be done with the patient’s careful consideration, and full understanding of the portfolio of options before them.
Stent Implant Efficacy Higher Without Cataract Surgery
June 25, 2024. Efficacy is higher for the Xen 45 gel stent implant as a standalone procedure than combined with cataract surgery. The Xen 45 gel stent implant provides effective, long-term treatment for open-angle glaucoma but there is a substantial rate of reoperation and needling, according to research published in British Journal of ...